As opposed to most solid cancers, hepatocellular carcinoma (HCC) does not necessarily
require histological confirmation. Noninvasive diagnosis is possible and relies on imaging …

MRI is widely used in clinical practice for detecting liver diseases. Since the introduction of
gadoxetic acid, MRI has become the most effective modality for the detection and …

Balanced hemostasis with hypocoagulable and hypercoagulable features may occur in
acute‐on‐chronic liver failure (ACLF). The characteristics and prognostic impact of the …

We intraindividually compared the efficacy of magnetic resonance imaging (MRI) with
extracellular contrast agents (ECA‐MRI) and MRI with hepatobiliary agents (HBA‐MRI) for …

Background Hepatobiliary phase (HBP) hypointense nodules without arterial phase
hyperenhancement (APHE) at gadoxetic acid–enhanced MRI may indicate hepatocellular …

We report the genetic analysis of a “humanized” hyperlipidemic mouse model for
progressive nonalcoholic steatohepatitis (NASH) and fibrosis. Mice carrying transgenes for …

The computed tomography/magnetic resonance imaging (CT/MRI) Liver Imaging Reporting
& Data System (LI‐RADS) is a standardized system for diagnostic imaging terminology …

Abstract The 10th Global Forum for Liver Magnetic Resonance Imaging (MRI) was held as a
virtual 2-day meeting in October 2021, attended by delegates from North and South …

Gadoxetic acid, a hepatocyte-specific magnetic resonance imaging (MRI) contrast agent,
has emerged as an important tool for hepatocellular carcinoma (HCC) diagnosis. Gadoxetic …

Use of gadoxetate disodium, a hepatobiliary gadolinium‐based agent, in patients with
chronic parenchymal liver disease offers the advantage of improved sensitivity for detecting …